Learn more

INFLAMMATORY RESPONSE RES INC

Overview
  • Total Patents
    46
  • GoodIP Patent Rank
    36,548
  • Filing trend
    ⇩ 60.0%
About

INFLAMMATORY RESPONSE RES INC has a total of 46 patent applications. It decreased the IP activity by 60.0%. Its first patent ever was published in 2011. It filed its patents most often in United States, EPO (European Patent Office) and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and environmental technology are NEUROMOLECULAR PHARMACEUTICALS, ADAMAS PHARMACEUTICALS INC and LYRIC PHARMACEUTICALS INC.

Patent filings per year

Chart showing INFLAMMATORY RESPONSE RES INCs patent filings per year from 1900 to 2020

Focus industries

# Industry
#1 Pharmaceuticals
#2 Environmental technology

Top inventors

# Name Total Patents
#1 May Bruce Chandler 43
#2 Chandler Bruce 2
#3 Bruce Chandler May 1

Latest patents

Publication Filing date Title
EP3193875A1 Levocetirizine and montelukast in the treatment of inflammation mediated conditions
KR20150138848A Use of levocetirizine and montelukast in the treatment of anaphylaxis
EP2969002A1 Use of levocetirizine and montelukast in the treatment of traumatic injury
KR20160125283A Use of levocetirizine and montelukast in the treatment of autoimmune vasculitis
EP3300734A2 Use of levocetirizine and montelukast in the treatment of autoimmune disorders
CN107308161A The purposes of levocetirizine and montelukast in treatment influenza, common cold and inflammation